Clinical Trial Update: Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery [Phase 1]

View source ↗

Summary

Phase 1 trial of topotecan in unresectable gynecologic cancers has completed. The study included cervical, endometrial, fallopian tube, ovarian cancers, and oth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Endometrial Cancer
• Fallopian Tube Cancer
• Ovarian Cancer
• Sarcoma
• Vaginal Cancer
• Vulvar Cancer

Drugs mentioned

• Hycamtin (Topotecan)

Snippet

Sponsor: Steven Waggoner, MD | Conditions: Cervical Cancer, Endometrial Cancer | Phase 1 | Status: COMPLETED